フォロー
Anita van den Hoek
Anita van den Hoek
TNO Dept. of Metabolic Health Research
確認したメール アドレス: tno.nl
タイトル
引用先
引用先
Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease
FE Dewey, V Gusarova, RL Dunbar, C O’Dushlaine, C Schurmann, ...
New England Journal of Medicine 377 (3), 211-221, 2017
7642017
Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology
W Liang, AL Menke, A Driessen, GH Koek, JH Lindeman, R Stoop, ...
PloS one 9 (12), e115922, 2014
5092014
Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin [S]
S Kühnast, JWA van der Hoorn, EJ Pieterman, AM van den Hoek, ...
Journal of lipid research 55 (10), 2103-2112, 2014
2302014
Metformin lowers plasma triglycerides by promoting VLDL-triglyceride clearance by brown adipose tissue in mice
JJ Geerling, MR Boon, GC van der Zon, SAA van den Berg, ...
Diabetes 63 (3), 880-891, 2014
1882014
Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance
R Kleemann, M van Erk, L Verschuren, AM van den Hoek, M Koek, ...
PloS one 5 (1), e8817, 2010
1792010
Intracerebroventricular administration of neuropeptide Y induces hepatic insulin resistance via sympathetic innervation
AM Van Den Hoek, C van Heijningen, JP Schroder-van der Elst, ...
Diabetes 57 (9), 2304-2310, 2008
1572008
Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin
AM van den Hoek, PJ Voshol, BN Karnekamp, RM Buijs, JA Romijn, ...
Diabetes 53 (10), 2529-2534, 2004
1452004
PYY3–36 reinforces insulin action on glucose disposal in mice fed a high-fat diet
AM Van Den Hoek, AC Heijboer, EPM Corssmit, PJ Voshol, JA Romijn, ...
Diabetes 53 (8), 1949-1952, 2004
1422004
Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity
MR Boon, S Kooijman, AD Van Dam, LR Pelgrom, JFP Berbée, ...
The FASEB Journal 28 (12), 5361-5375, 2014
1212014
Ghrelin differentially affects hepatic and peripheral insulin sensitivity in mice
AC Heijboer, AM van den Hoek, ET Parlevliet, LM Havekes, JA Romijn, ...
Diabetologia 49, 732-738, 2006
1202006
Gut–brain axis: regulation of glucose metabolism
AC Heijboer, H Pijl, AM Van den Hoek, LM Havekes, JA Romijn, ...
Journal of neuroendocrinology 18 (12), 883-894, 2006
1102006
Chronic PYY3–36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice
AM Van Den Hoek, AC Heijboer, PJ Voshol, LM Havekes, JA Romijn, ...
American Journal of Physiology-Endocrinology and Metabolism 292 (1), E238-E245, 2007
1042007
Metabolically induced liver inflammation leads to NASH and differs from LPS-or IL-1β-induced chronic inflammation
W Liang, JH Lindeman, AL Menke, DP Koonen, M Morrison, LM Havekes, ...
Laboratory investigation 94 (5), 491-502, 2014
882014
APOE* 3Leiden. CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome
AM van den Hoek, JWA van der Hoorn, AC Maas, RM van den Hoogen, ...
Diabetes, Obesity and Metabolism 16 (6), 537-544, 2014
662014
Obeticholic acid modulates serum metabolites and gene signatures characteristic of human NASH and attenuates inflammation and fibrosis progression in Ldlr‐/‐. leiden mice
MC Morrison, L Verschuren, K Salic, J Verheij, A Menke, PY Wielinga, ...
Hepatology communications 2 (12), 1513-1532, 2018
572018
Intracerebroventricular administration of melanotan II increases insulin sensitivity of glucose disposal in mice
AC Heijboer, AM Van Den Hoek, H Pijl, PJ Voshol, LM Havekes, ...
Diabetologia 48, 1621-1626, 2005
572005
Uncovering a predictive molecular signature for the onset of NASH-related fibrosis in a translational NASH mouse model
A van Koppen, L Verschuren, AM van den Hoek, J Verheij, MC Morrison, ...
Cellular and molecular gastroenterology and hepatology 5 (1), 83-98. e10, 2018
522018
Salsalate activates brown adipose tissue in mice
AD Van Dam, KJ Nahon, S Kooijman, SM Van Den Berg, AA Kanhai, ...
Diabetes 64 (5), 1544-1554, 2015
522015
Overexpression of APOC1 in obob mice leads to hepatic steatosis and severe hepatic insulin resistance
M Muurling, AM van den Hoek, RP Mensink, H Pijl, JA Romijn, ...
Journal of lipid research 45 (1), 9-16, 2004
522004
The CCR2 inhibitor propagermanium attenuates diet-induced insulin resistance, adipose tissue inflammation and non-alcoholic steatohepatitis
P Mulder, AM van den Hoek, R Kleemann
PloS one 12 (1), e0169740, 2017
502017
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20